Nobuharu Tamaki

68PUBLICATIONS
138CO-AUTHORS
Predictive and prognostic markersComputational physiologyMolecular medicineFood properties (incl. characteristics and health benefits)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Apr 02, 2026
Comparative diagnostic performance of ultrasound-guided attenuation parameter versus B-mode scoring for hepatic steatosis assessment: an ordinal-scale statistical approach.

Takashi Kumada, Hidenori Toyoda, Sadanobu Ogawa

|Feb 09, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

Takanori Suzuki, Kentaro Matsuura, Yuki Tahata

|Jan 29, 2026
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients.

Nobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi

|Jan 27, 2026
Metabolic dysfunction-associated steatotic liver disease (MASLD): definition, diagnosis, natural history, and treatment.

Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi

|Dec 08, 2025
Chronic Hepatitis B Infection: Patient Guidance.

Lung-Yi Mak, Jimmy Che-To Lai, Ken Liu

Pageof 12

Frequent Collaborators

14 joint publications

Rohit Loomba

11 joint publications

Yutaka Yasui

8 joint publications

Kaoru Tsuchiya

8 joint publications

Daniel Q Huang